Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Journal of the American College of Nutrition ◽

10.1080/07315724.2015.1021057 ◽

2015 ◽

Vol 35 (4) ◽

pp. 346-353 ◽

Cited By ~ 36

Author(s):

Farnaz Farsi ◽

Majid Mohammadshahi ◽

Pezhman Alavinejad ◽

Afshin Rezazadeh ◽

Mehdi Zarei ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Coenzyme Q10 ◽

Fatty Liver Disease ◽

Liver Enzymes ◽

Double Blind ◽

Double Blind Placebo ◽

Coenzyme Q10 Supplementation

The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled clinical trial

10.1002/ptr.6424 ◽

2019 ◽

Vol 33 (9) ◽

pp. 2369-2377 ◽

Cited By ~ 2

Author(s):

Mina Darand ◽

Zahra Darabi ◽

Zahra Yari ◽

Mehdi Hedayati ◽

Mohammad Amin Shahrbaf ◽

...

Keyword(s):

Risk Factors ◽

Clinical Trial ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Clinical Trial ◽

Double Blind ◽

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

BMC Research Notes ◽

10.1186/s13104-019-4130-6 ◽

2019 ◽

Vol 12 (1) ◽

Cited By ~ 7

Author(s):

Zahra Darabi ◽

Mina Darand ◽

Zahra Yari ◽

Mehdi Hedayati ◽

Amirhosein Faghihi ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Inflammatory Markers ◽

Fatty Liver Disease ◽

Controlled Clinical Trial ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2018.09.010 ◽

2018 ◽

Vol 41 ◽

pp. 118-123 ◽

Cited By ~ 5

Author(s):

Nasrindokht Zamani ◽

Mesbah Shams ◽

Majid Nimrouzi ◽

Mohammad Mehdi Zarshenas ◽

Amin Abolhasani Foroughi ◽

...

Keyword(s):

Insulin Resistance ◽

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Clinical Trial ◽

Double Blind ◽

Zataria Multiflora ◽

Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double‐blind clinical trial

10.1002/ptr.6972 ◽

2021 ◽

Author(s):

Reyhaneh Darvish Damavandi ◽

Farzad Shidfar ◽

Mohammad Najafi ◽

Leila Janani ◽

Mohsen Masoodi ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Lipid Profile ◽

Fatty Liver Disease ◽

Liver Enzymes ◽

Glycemic Status ◽

Double Blind ◽

Double Blind Clinical Trial

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

American Journal of Clinical Nutrition ◽

10.3945/ajcn.113.068890 ◽

2014 ◽

Vol 99 (3) ◽

pp. 535-542 ◽

Cited By ~ 162

Author(s):

Tannaz Eslamparast ◽

Hossein Poustchi ◽

Farhad Zamani ◽

Maryam Sharafkhah ◽

Reza Malekzadeh ◽

...

Keyword(s):

Liver Disease ◽

Pilot Study ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Synbiotic Supplementation

Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial

International Journal of Food Sciences and Nutrition ◽

10.1080/09637486.2020.1746957 ◽

2020 ◽

Vol 71 (8) ◽

pp. 991-1000

Author(s):

Razie Hormoznejad ◽

Majid Mohammad Shahi ◽

Fakher Rahim ◽

Bijan Helli ◽

Pezhman Alavinejad ◽

...

Keyword(s):

Clinical Trial ◽

Weight Loss ◽

Liver Disease ◽

Fatty Liver ◽

Randomized Clinical Trial ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double‐blind randomized clinical trial

10.1002/ptr.6791 ◽

2020 ◽

Vol 34 (12) ◽

pp. 3367-3378

Author(s):

Farnaz Kaviani Pour ◽

Naheed Aryaeian ◽

Marjan Mokhtare ◽

Reyhane Sadat Mirnasrollahi Parsa ◽

Leila Jannani ◽

...

Keyword(s):

Clinical Trial ◽

Body Composition ◽

Liver Disease ◽

Fatty Liver ◽

Randomized Clinical Trial ◽

Fatty Liver Disease ◽

Double Blind ◽

Oxidative Markers

Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial

Annals of Hepatology ◽

10.1016/s1665-2681(19)32103-9 ◽

2004 ◽

Vol 3 (3) ◽

pp. 108-112 ◽

Cited By ~ 38

Author(s):

Nahum Méndez-Sánchez ◽

Verónica González ◽

Norberto Chávez-Tapia ◽

Martha H Ramos ◽

Misael Uribe

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Ursodeoxycholic Acid ◽

Weight Reduction ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Double Blind ◽

Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

10.1002/ptr.6406 ◽

2019 ◽

Vol 33 (8) ◽

pp. 2118-2125 ◽

Cited By ~ 8

Author(s):

Makan Cheraghpour ◽

Hossein Imani ◽

Shahrzad Ommi ◽

Seyed Moayed Alavian ◽

Elahe Karimi‐Shahrbabak ◽

...

Keyword(s):

Clinical Trial ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Hepatic Enzymes ◽

Double Blind ◽

Inflammatory Parameters ◽

Double Blind Clinical Trial